[Treatment of acute sinusitis using new quinoline chemotherapeutic agents].
The author compared in an open clinical trial during treatment of acute sinusitis the therapeutic results of two new quinoline chemotherapeutic preparations--Tarivid and Ciproxine. The drugs were administered to a total of 40 patients. In both groups (à 20 patients) clinical recovery occurred in 95% of the patients. The preparations were well tolerated and no manifestations of allergy or marked intolerance were observed. Regular haematological and biochemical tests did not reveal a pathological rise of parameters. No difference was revealed in the therapeutic effectiveness of the two drugs.
Dolejs
Z
Z
Subkatedra dĕtské otolaryngologie ILF a ORL oddĕlení dospĕlých, Fakultní Thomayerovy nemocnice, Praha.
D042462:4-Quinolones; D000208:Acute Disease; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D012852:Sinusitis / Q000188:drug therapy*
D042462:4-Quinolones; D000890:Anti-Infective Agents
Lécba akutních sinusitid novými chinolinovými chemoterapeutiky.